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based on aggregate data and results from a prospective
intervention study.
Setting: The cost-effectiveness study was based in the
general community. The prospective study was hospital
based, as 85% of the first-time hearing-aid users attend
a hospital in the process of hearing-aid fitting.
Patients: The prospective intervention study included
adult first-time hearing-aid users with no contraindica-
tions for hearing-aid use.
Intervention: The usual process of hearing-aid fitting
in the Netherlands.
Main Outcome Measure:Costsperquality-adjustedlife-
year (QALY). The QALYs were based on EuroQol scores.
We included direct and indirect costs in the analysis.
Results: The mean improvement on the EuroQol mea-
sure was 0.03 (95% confidence interval [CI], −0.03 to
0.08),andonthehearing-specificvisualanalogscale,0.27
(95% CI, 0.22-0.31). The base-case outcome based on the
EuroQol was C15807/QALY (US $17072/QALY) (CI,
−C24239/QALY to C3718/QALY).
Conclusions:Onthebasisofthisbase-caseestimate,fit-
ting of hearing aids is considered a cost-effective health
care intervention. The CI indicates that the result is not
unambiguously positive, probably because the EuroQol
lacked sensitivity for the evaluation of hearing-aid fit-
ting. Until now, no study has found an effect of hearing-
aid fitting on generic quality of life. Therefore, mea-
sures are needed that are suitable for the evaluation of
the effects of interventions for sensory disabilities, such
asthefittingofhearingaids,ongenericqualityoflife.
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EARING IMPAIRMENT is a
very common condi-
tion, the onset of which
istightlycoupledwithag-
ing. When defined as an
averagepure-tonehearinglossinthebest
ear of 35 dB or more at 1, 2, and 4 kHz,
hearing impairment was found in 75% of
thepopulationolderthan80years.1Asthe
prevalence of hearing impairment in-
creases rapidly with age, hearing impair-
ment will be one of the most prevalent




Little information about the eco-
nomic consequences of hearing impair-
menttosocietyisavailable.IntheUnited
States,thelifetimecostsofprofoundtose-
vere hearing loss (defined as hearing
thresholdsof70dBaveragedacrossthe
frequencies 0.5, 1, and 2 kHz) when on-
set is at older than 60 years were esti-
mated to be on average US $43000.3 The
useofhearingaidshasbeenshowntoim-
provesocial,emotional,andcommunica-
tion functions and to reduce depression.2
Although in most cases of sensorineural
hearing impairment, a hearing aid is the
only option for rehabilitation, only a few
studiescalculatedthecostsandeffectsas-
sociated with hearing-aid fitting.4-7 How-
ever,noneofthesestudiesfocusedonthe
societal costs and effects of hearing-aid
fittings, and no study performed a cost-
effectiveness analysis.
Theobjectiveofthisstudywastode-
termine the cost-effectiveness of fitting
hearing aids in adult hearing-impaired
persons compared with that of not fitting
them in the Netherlands. All costs are re-
ported in Eurocurrency (C1=US $1.08,
1998 conversion rate). The results from
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ers were combined with observational data to obtain a
realistic view of the economic impact of hearing-aid fit-
ting on society. All data were incorporated in a simu-
lated cohort model of hearing disability in the popula-
tion. The study results are reported in the following 2
cost-effectivenessratiosforhearing-aidfitting:costsper
quality-adjustedlife-year(QALY)andcostsperhearing-
related QALY (hearing-QALY). The latter is a combined
measureofeffectthatisbasedonlifeexpectancyandhear-
ing-specific quality of life.
METHODS
MODEL OF HEARING-AID FITTING
The assessment of the effect of hearing-aid fitting on the qual-




so on. In a dynamic model, the population is divided among
differenthealthstates;overtime,personsmovefromonehealth
statetoanotheraccordingtocertaintransitionprobabilitiesthat
can be assessed empirically. These models are often referred
toasstate-transitionorMarkovmodels.Markovmodelsarepar-
ticularlyusefulwhenmodelingdecisionproblemsinvolvingon-
going risk.8 We used cohort simulation to evaluate the model,
ie, a fixed number of persons per age group were followed up
during their lifetime (Figure 1).
The cohort ceased to exist when all members of the cohort
group had died. The model ran with steps of 1 year, and during
that year persons moved between the different health states, re-
sulting in a new distribution of persons among the health states
on the first day of the next year. The starting year of the model
was1995,andmortalityfigureswerebasedondatafromtheCen-
tral Bureau of Statistics for that year. Future costs and benefits
werediscountedtotheirpresentvaluebyarateof5%.Boasetal9
described the technical and methodological merits of dynamic
modeling in the case of hearing-aid fitting more extensively.
The model distinguishes among the following 3 different
groupsofpatients:thosewithhearingcomplaintswithoutahear-
ing aid (non–hearing-aid users with hearing complaints), those
with hearing complaints who are satisfied with their hearing aid
(satisfied hearing-aid users), and those with hearing complaints
who are dissatisfied with their hearing aid (dissatisfied hearing-
aid users). From these health states, persons can enter the diag-
nostics-and-treatment phase (Figure 1). In the Netherlands, all
patients must first consult their general practitioner (GP) for re-
ferral to an ear, nose, and throat (ENT) specialist or an audio-
logicalcenter(AC).OnlyENTspecialistsandaudiologistsareen-
titled to prescribe hearing aids. The ACs offer multidisciplinary
specialized help for the more serious or complicated cases. The
actual hearing-aid fitting takes place at a hearing-aid dispenser.
Once a satisfying hearing-aid fit is obtained, the patient returns
to the ENT specialist or the AC for approval of the fitted hearing
aid. The approval entitles the patient to (partial) reimbursement
of the cost of the hearing aid.
STUDY POPULATION
Aprospectivestudyofhearing-aidfittingwasperformedatthe
ENT clinic of the University Hospital Maastricht, Maastricht,
the Netherlands, in collaboration with the Hoensbroeck Au-
diological Centre, Hoensbroeck, the Netherlands. The medi-
cal ethics committee of the university hospital approved the
study.Hearing-impairedpersons18yearsandolderwereasked
toenterthestudywhentheyreceivedaprescriptionforahear-
ing aid from their ENT specialist or audiologist. Immediately
after their written informed consent was obtained, the base-
line measurement took place. This measurement consisted of
pure-tone audiometry and a questionnaire. A hearing-aid dis-
penser then performed the hearing-aid fitting. After the trial
period, when a satisfying fit of the hearing aid was obtained,
the patient visited the ENT specialist or audiologist again, and
the fit of the hearing aid was evaluated and eventually ap-
proved.Thefollow-upmeasurementwasscheduledat4months
after baseline at the ENT clinic or the AC.
From February 1, 1998, to March 31, 1999, 126 hearing-
impairedpersonsenteredthestudy.Ofthese,28%attendedthe
UniversityHospitalMaastrichtand72%attendedtheAC.Forty-
eight persons left the study owing to lack of a hearing aid that
fit (n=17), death (n=2), illness (n=2), own request (n=15),
andlosttofollow-upforunverifiablereasons(n=12).Seventy-
eightpatientscompletedthethirdandfinalmeasurement(mean
age, 69.1 years [range, 29-96 years]). The mean hearing loss
was47.4dBat1,2,and4kHzinthebestear.Thepatientswho
left the study were somewhat younger (mean age, 65.5 years),
andhadsomewhatbetterhearing(43.5dB)thanthosewhocom-
pleted the study. Approximately half of the participants were
male (42 [54%]), and 52 were married (67%). Sixty-two pa-
tients were fitted with a hearing aid behind the ear (79%). Of
the remainder, 14 (18%) were fitted with an in-the-ear hear-
ing aid and only 2 (3%) with an in-the-canal hearing aid.
QUALITY-OF-LIFE ASSESSMENT
Generic Quality of Life
To measure change in overall health-related quality of life, we
used the EuroQol 5 Dimensions (EQ-5D).10 This generic mea-
















Figure 1. A model of hearing-aid fitting in the Netherlands. ENT indicates
ear, nose, and throat specialist; AC, audiological center.
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and complaints, and feeling), a question about health transi-
tion, and a visual analog scale (VAS). The answers on the VAS
can be interpreted as patient scores. Dolan11 developed an al-
gorithm to calculate population utilities from the patient data.
Specific Quality of Life
The sensitivity of the EQ-5D, as for virtually all generic mea-
sures, was perceived to be suboptimal for detecting changes in






quality of life (Horst Zank, PhD, M.A.J, H.J.M.P., G.M.B., and








hearing aids.14 On the basis of the results of an epidemiological




older have hearing complaints but no hearing aid. Of the popu-
lationwithhearingcomplaintswhowereyoungerthan60years,
67% was male, compared with 50% in the general population
youngerthan60years.Approximately132000non–hearing-aid
users 15 years and older contact their GP with hearing com-
plaintsforthefirsttimeeachyear(incidence,9.2/1000patients).15
On the basis of age-specific incidence data, we calculated the av-
erage transition probability of contacting the GP from the popu-
lation of non–hearing-aid users with hearing complaints to be
4.28% for persons aged 15 to younger than 60 years and 16.44%
for those 60 years and older.15
Diagnostics-and-Treatment Phase
Of the persons who visit the GP because of hearing problems,
45% are not referred to an ENT specialist or an AC.1 When re-
ferred to the ENT specialist or the AC, 75% receive a prescrip-
tion for a hearing aid.14 Eventually, somewhat more than 7%
of all hearing-aid trials end without the purchase of a hearing
aid.16TheprobabilitiesoffirstseeingtheGPandeventuallyhav-
ing a hearing aid fitted are the same for men and women.14 All
hearing-aid reapplicants (satisfied and dissatisfied) are as-
sumed to go through all treatment stages and end up with a




entered the satisfied hearing-aid users population, since it was




Since this phenomenon seemed more prevalent in older per-
sons,17weassumedthatoftheinflowtothedissatisfiedhearing-
aid users population, the proportion of persons aged 15 to
younger than 60 years was 10%, vs 90% of persons 60 years
and older. This assumption resulted in transition probabilities
of6.08and12.16,respectively.BasedonthestudybyGrootveld
et al,18 12% from the dissatisfied hearing-aid users were trans-
ferred to the non–hearing-aid users population annually,
because they no longer used their hearing aids.
The average replacement time of the patients in the sat-
isfied hearing-aid users population was calculated by correct-
ing the annual number of hearing aids sold for the proportion
ofhearingaidssoldtofirst-timehearing-aidusersandformor-
tality in the population of satisfied hearing-aid users. We as-
sumed that the average replacement time of irregularly used
hearing aids was approximately double the replacement time
of hearing aids used by satisfied patients.
Mortality
All populations were adjusted for mortality annually. Mortal-
ity rates were specific for age (5-year age groups) and sex.
COSTS
Inthisstudy,weconsideredcostsfromasocietalpointofview.
Societal costs consist of the extra health care and non–health
care costs (regardless of who pays for them) decreased by sav-
ings resulting from the possible gain in productivity related to
the intervention. The direct health care costs included in the
study were associated with consultations (GP, ENT specialist,
orAC),diagnostics(audiometry),hearing-aidfitting,thehear-
ing-aid instrument, and hearing-aid use (batteries and repair).
Direct non–health care costs such as time spent and the costs
of travel associated with the fitting of the hearing aid and its
use were not quantified. Possible savings in terms of increased
productivity were assessed in the prospective study of first-
time fitting of hearing aids. The most recent price information
was from 1998, so all costs were based on the 1998 price level.
On July 1, 1998, C1.0 equaled US $1.08. Table 1 provides a
summary of all cost input.
GP Consultation
In1998,thecostsperGPconsultationwereonaverageC16.26.19
Only the costs of the GP consultations related to the referral
to the ENT specialist or AC were counted. This number was
estimated at 1.5 consultations per person, and the costs of GP
consultations related to fitting of hearing aids were C24.40.
ENT Clinic
In the Netherlands, 85% of all hearing-aid fittings are per-
formed through an ENT clinic. The costs per ENT consultation
in 1998 were on average C28.26 (based on a low-estimate, non-
university hospital).19 During the process of hearing-aid fitting,
the ENT specialist was visited once for diagnosis of the hearing
impairment and prescription of a hearing aid and once for the
approval of the fitted hearing aid. At both consultations in the
ENT clinic, tone and speech audiometry was performed to di-
agnose hearing impairment and evaluate the fitted hearing aid.
The costs of the audiometry were based on weighted averages
ofthechargesforvoluntaryandcompulsoryinsurance.In1998,
the costs for tone audiometry were C29.55 and those for speech
audiometrywereC63.65.ThetotalcostsoftheENTclinicamount
to C242.92 per each successful hearing-aid fitting (C121.46 per
consultation). We assumed that after a negative result of a trial
atthehearing-aiddispenser,only50%ofthepersonswouldcon-
sulttheENTspecialistafterward,andthatnoaudiometrywould
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the ENT clinic after a negative trial result amounted to C28.26.
Audiology Center
Of all hearing-aid fittings, 15% are performed through an AC.
The charge for the AC was C216 in 1998. For this amount,
audiometry and an extensive counseling and rehabilitation
program (when indicated) are performed.
Hearing-Aid Dispenser
Weassumedthateverypersonwhoreceivesaprescriptionsees
a dispenser. The costs of a negative trial result at the hearing-
aid dispenser were estimated to amount to the dispenser’s fee
in the price of a hearing aid (39%).21
Hearing Aids
IntheNetherlands,amarketstudyoftheaveragepurchasecosts
of a hearing aid found an average price of C636.00 in 1995.22
Thispricewascorrectedforpricedifferencesfrom1995to1998
using the Dutch health care price index figures,19 resulting in
an average price of C671.00 in 1998. According to the market
studyoftheDutchAssociationofHearingAidDispensers,25%
of all sales are binaural fittings,16 in which case the costs are
doubled.Costsresultingfromtheuseofhearingaidswerecosts
ofbatteriesandrepair.Theaverageyearlycostsofbatterieswere
Table 1. Model Input Variables
Variable Base-Case Estimate Range of Estimate* Source (Year)
Parameter for non−hearing-aid users with hearing complaints
Annual probability to visit GP for hearing-related complaints, %
60 y 4.3 2.1 to 8.6 Chorus et al15 (1995)
60 y 16.4 8.2 to 32.9 Chorus et al15 (1995)
Diagnostics-and-treatment phase, %
Annual probability to be referred by GP 54.5 40 to 70 Abutan et al1 (1993)
Annual probability to receive prescription for an HA 75.0 62.5 to 87.5 Streukens and Leenen16 (1996)
Annual probability of negative trial result at dispenser 7.4 3.7 to 11 Streukens and Leenen16 (1996)
Satisfied and dissatisfied hearing-aid users
Annual probability to become dissatisfied HA user, %
60 y 6.1 0 to 12 Chorus et al15 (1995)
Grootveld et al18 (1989)
60 y 12.2 12 to 24 Chorus et al15 (1995)
Grootveld et al18 (1989)
Annual probability to become a non-HA user, % 12.0 . . . Grootveld et al18 (1989)
Time to hearing-aid replacement, y
Satisfied HA user 8.2 4.1 to 12.4 Expert opinion
Dissatisfied HA user 15.0 7.5 to 22.5 Expert opinion
Mortality, annual age- and gender-specific mortality 5-y Age categories . . . CBS13 (1994)
Gain in generic quality of life
Patient score on the EQ-5D VAS 0.02 −0.02 to 0.05† This study
Population utility estimate EQ-5D 0.03 −0.03 to 0.08† This study
Gain in hearing-specific quality of life, patient score
on the hearing-specific VAS
0.27 0.22 to 0.31† This study
Costs
GP consultations, C 24.40 . . . Oostenbrink et al19 (2000)
ENT clinic, C
First consultation 121.46 121.46 to 177.99 Oostenbrink et al19 (2000)‡
Follow-up consultation after successful trial
at the dispenser
121.46 121.46 to 177.99 Oostenbrink et al19 (2000)‡
Follow-up consultation after negative trial result
at the dispenser
28.26 28.26 to 84.79 Oostenbrink et al19 (2000)‡
Audiological center, C 216.09 . . . Charge information
Ratio hearing-aid fittings through ENT clinic/AC, C 5/15 . . . Expert opinion
HA, C 670.69 350 to 1000 Mot and Meulenbeck22 (1997)
Proportion binaural fittings, % 25 10 to 50 Streukens and Leenen16 (1996)
Dispenser negative trial per HA, C 261.69 137 to 390 Mot and Meulenbeck22 (1997),
Ziekenfondsraad (1994)21
HA battery costs for satisfied HA users, C 34.31 . . . Consumers’ information, Verlare20 (1985)
HA battery costs for dissatisfied HA users, C 10.04 . . . Consumers’ information, Verlare20 (1985)
HA repair costs for satisfied HA users, C 18.75 9.80 to 28.00 NVAB information§
HA repair costs for dissatisfied HA users, C 9.38 4.90 to 14.00 NVAB information§
Savings as a result of reduced productivity loss, C 0.00 . . . This study
Abbreviations: AC, audiological center; CBS, Central Bureau of Statistics; ENT, ear, nose, and throat specialist; EQ-5D, EuroQol 5 Dimensions; GP, general
practitioner; HA, hearing aid; NVAB, Nederlandse Vereniging van Audiciens Bedrijven (Dutch Association of Hearing Aid Dispensers); VAS, visual analog scale.
*Ellipses indicate data not available.
†Range indicates 95% confidence interval.
‡Indicates charge information.
§H. Streukens, oral communication, 1999.
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fied users (available at the Web site for the NVVS [Neder-
landseVerenigingVoorSlechthorenden(DutchAssociationfor
theHardofHearing)],http://www.nvvs.nl).Onaverage,behind-
the-ear hearing aids were repaired 1.2 times per 5 years and
in-the-earhearingaids,1.9timesper5years.Theaveragecosts
per repair were estimated at C68.18.16 Based on the ratio of be-
hind-the-ear–in-the-earhearingaids(75:25),theaverageyearly
repair costs per hearing aid were estimated at C18.75.
Productivity Loss
Only 10 persons in the prospective hearing-aid fitting study
(12.8%)performedpaidlabor.Thisfindingseemednormalaf-
ter we considered the age distribution of a population of adult
first-time hearing-aid applicants. They did not report any ab-
sence from work due to hearing impairment or other health
problems.23 Based on these results, in this population of mod-
erately hearing-impaired first-time hearing-aid users, no costs
result from productivity loss due to not being fitted with hear-
ing aids. As a consequence, no savings result from a possible
gain in productivity after a hearing-aid fitting.
COST/QALY CALCULATION
We assumed that only satisfied hearing-aid users would experi-
ence a gain in quality of life as a result of fitting of a hearing aid.
The total amount of QALYs gained was computed by counting
the total number of satisfied users in a certain year, multiplied
by the change in the population utility estimate from the EQ-
5D,andaddedacrossthetotallifeexpectancy.Age-specificcost/
QALYratioswerecalculatedbydividingthetotalamountofcosts
by the total amount of QALYs gained in the specific age cat-
egory. To calculate the overall cost/QALY ratio, the distribution
of persons across the age categories should match the distribu-
tion of persons eligible for a hearing aid (persons with hearing
complaints)atthepopulationlevel.Otherwise,theaveragecost/
QALY ratio might not be representative at the population level,




In the calculation of the costs/hearing-QALY outcome, we used
the gain on the hearing-specific VAS.
ANALYSIS
We used descriptive statistics to describe the characteristics of
the study population. The results of the EQ-5D (the VAS and
population utility estimate) and the hearing-specific VAS are
reported as mean±SD. We compared the scores before and af-
ter fitting of the hearing aids on the EQ-5D and the hearing
VAS by means of the paired-samples t test when normally dis-
tributed or the Wilcoxon signed rank test when not normally
distributed.Weusedthe95%confidenceintervalofthechanges
intheEQ-5Dpopulationutilityestimateandhearing-VASscore
with the highest and lowest estimates of the costs to construct
cost-effectiveness confidence boxes on the cost-effectiveness
plane to present the confidence limits of the estimates of
the cost/QALY and cost/hearing-QALY outcomes. The
cost-effectiveness plane is a coordinate system with the incre-
mental costs on the y-axis and the incremental effects on the
x-axis and is often used to show the outcomes of cost-
effectiveness studies.25 The 4 quadrants represent the 4 pos-
sibleoutcomesofincrementalcostsandhealtheffectsofanew
health intervention. Univariate sensitivity analysis was per-
formed to test the robustness of the cost/QALY outcomes for





tial and highly statistically significant improvement after
hearing-aid fitting (0.27 [95% confidence interval, 0.22-
0.30]; P.001, paired t test), whereas the result on the
EQ-5D VAS (patient preferences) and the EQ-5D popula-
tion utility estimate showed only a small and nonstatisti-
cally significant gain in quality of life (0.02 and 0.03, re-
spectively) (Table 1).
COST OUTCOMES
The average costs of fitting hearing aids in a population
of persons with hearing complaints amount to C781
(base-case estimate, discounted). Of this amount, 60%
is spent on hearing aids, 16% on hearing-aid batteries
and repair, and 14% on direct health care costs (GP,
ENT clinic, and AC). Based on the highest estimates for
all cost variables, the average incremental costs amount
to C1.197, and based on the lowest estimates, the aver-
age incremental costs amount to C490.
COST/QALY OUTCOMES
Based on the average outcome per patient of the EQ-5D
population utility estimate (mean utility gain, 0.03) as a
resultoffittingofhearingaidsinthetotalpopulationwith
hearing complaints, on average 0.05 QALYs are gained.
The cost/QALY outcome ranges from C11984 in the
youngest to C34902 in the oldest groups. The increase
withageisduetoincreasingmortalityduringthelifespan
of a hearing aid in older groups. As a result, the out-
comes are also slightly less beneficiary for male com-
pared with female hearing-aid users in the groups older
than50years.Theaveragecost/QALYoutcomeamounts
to C15807/QALY. This outcome is considered a base-
case estimate.
When using the patient scores on the EQ-5D VAS,
an average of 0.03 QALYs were gained per person. The
cost/QALY outcome ranged from C17996 in the group
aged 15 to 19 years to C52502 in the group aged 95 to
99 years (average, C23745/QALY).
Based on the average gain in hearing-related qual-
ity of life, 0.44 hearing-QALYs were gained. The costs/
hearing-QALYoutcomesrangedfromC1333intheyoung-
estgroupto C3889intheoldestgroup.Theoverallcosts/
hearing-QALY ratio amounts to C1759 (Figure 2).
The QALYs gained using the lower (−0.03) and
upper (0.08) limits of the 95% CI of the average incre-
mentalpopulationutilitycombinedwiththehighestand
lowestincrementalcostestimatesresultinworst-andbest-
case scenarios. The cost/QALY outcome in the worst-
casescenarioamountsto C24239perQALYlost,andthe
cost/QALY outcome in the best-case scenario amounts
to C3718 per QALY gained. Based on these outcomes, a
confidenceboxwasconstructedaroundthebase-casecost/
QALY outcome.
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thelowerandupperboundoftheQALYsgainedusingthe
increase in hearing-related quality of life are used to con-
struct a confidence box for the cost/hearing-QALY out-
come. In the worst-case scenario in this hearing-specific
perspective,thecostsareC3305perhearing-QALYgained;
in the best-case scenario, the costs are C959 per hearing-
QALY gained (Figure 3).
SENSITIVITY ANALYSIS
The base-case outcome (C15807/QALY, based on the
average incremental population utility of 0.03) is used
as input in the univariate sensitivity analysis. Change in
quality of life had by far the most impact on the cost/
QALY outcome. When we varied the utility gain from
−0.03 to 0.08, the cost/QALY ranged from −C15807
to C5936.
WhenthepriceperhearingaidwasvariedfromC350
to C1000, the cost/QALY outcome varied from C11209
to C20575. When the binaural fitting is changed from the
base-case estimate of 25% to 10% and 50%, the outcome
changes from C14560/QALY to C17948/QALY. When the
replacementtimeofahearingaidwashalvedanddoubled,
theoutcomevariedfromC14402/QALYtoC20175/QALY.
Among the transition variables in the sensitivity analysis,
becoming a dissatisfied hearing-aid user had the largest
impact on the outcome. When the chance of becoming
dissatisfied was halved and doubled, the outcome varied
from C11280/QALY to C20283/QALY. The other transi-
tionvariablesinthesensitivityanalysishaveonlylittleeffect
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Figure 2. Age-specific cost per quality-adjusted life-year (QALY) outcomes for hearing-aid fitting based on population utility ( [change from before to after],
















–6 –5 –4 –3 –2 –1 0 1 2 3 4 5 6 7 8 9 10 11 13 14 15
  3718/QALY
   959/Hearing-QALY
   1759/Hearing-QALY




































Figure 3. Confidence boxes on the cost-effectiveness plane representing the worst- and best-case outcomes using the 95% confidence intervals of the population
utility estimate (A) and the hearing visual analog scale score (B), with the range in cost outcomes. E ¯L and E ¯U indicate the lower and upper limits, respectively, of
the incremental health effects; CL and CU, the lowest and highest incremental cost estimates, respectively; QALY, quality-adjusted life-year; and hearing-QALY,
hearing-related QALY. The combination of lower and upper limits of costs and effects is indicated by the confidence box (shaded area) around the base-case
estimate; 100 indicates that the numbers on the axes represent 100 times the actual incremental effect.
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Giventhebaseestimateofinputvariables,fittingofhear-
ing aids costs society from C11997/QALY in the young-
est group to C35001/QALY in the oldest group. The av-
erageoutcomeacrossallagesis C15807/QALY.Laupacis
et al26 found that the reimbursement of interventions
costinglessthanCAN$20000/QALYwasgenerallynever
questioned (CAN $20000=C16000). The base-case es-
timate of C15807/QALY for fitting hearing aids is
approximately CAN $20000/QALY. Based on this out-
come, fitting hearing aids could be considered a cost-
effectivehealth-careintervention.However,theeffectof
hearing-aid fitting on generic quality of life could not be
determined unambiguously, since the 95% CI of the
change in quality of life after fitting of the hearing aid,
as measured by the EQ-5D, included zero. As a result,
theconfidenceboxaroundthecost/QALYoutcome(Fig-
ure 2) clearly shows that we cannot rule out that not fit-
tinghearingaidsismorecost-effectivethanfittingthem.
Theimprovementonthehearing-VAS,however,wassub-
stantial and statistically significant. Therefore, we con-
firmed the effectiveness of hearing-related improve-
ment of quality of life due to hearing aids. This finding
could indicate that the EQ-5D lacked sensitivity for the
purposeofthisstudy.Althoughthisseemshighlylikely,
no study has been able to demonstrate an effect of fit-
ting a hearing aid on generic quality of life using a mea-
sure suitable for use in cost-effectiveness analysis.27,28
Otherprominentgenerichealthstatusmeasures,likethe
36-ItemShort-FormHealthSurveyandtheHealthUtili-
ties Index Mark II, would also have limitations for this
purpose. The 36-Item Short-Form Health Survey con-
tainsveryfewitemsthatcouldbeinfluencedbythepsy-
chological, social, and emotional consequences of hear-
ingimpairment.29AccordingtotheHealthUtilitiesIndex
Mark II scoring formula, being deaf and blind generates
the same amount of disutility as being only deaf or only
blind, which is a counterintuitive outcome.29 Overall,
health status measures are needed for the evaluation of
the effect of interventions for sensory disabilities, such
as hearing aids, on generic quality of life.
Thehearing-specificVASwasusedtodeterminethe
weightsforthecalculationofhearing-specificQALYs.This
type of QALY could be useful as a measure of effective-
ness in studies determining the incremental cost-
effectiveness of binaural vs monaural fitting and among
different types of hearing aids. For this purpose, a mul-
tiattribute preference-based questionnaire has been de-
veloped around the hearing-specific VAS (Horst Zank,
PhD, M.A.J, H.J.M.P., G.M.B., and L.J.C.A., unpub-
lished data, January 2002).12
Thecost-effectivenessofaninterventionisonly1cri-
terion for inclusion in the basic package of social insur-
ance.Thenecessityoftreatmentfortheindividualandthe
severity of the disease are also criteria for the inclusion of
an intervention in the basic package. Hearing impairment
is often trivialized as a normal aspect of aging and associ-
ated with stigmatized conditions such as mental disor-
ders.30 This could lead to a lower perception of the sever-




vancing technological possibilities of hearing aids and the
relatedincreaseofthepriceofhearingaids,theamountof
reimbursementmightbecomeabarriertoseekingoftreat-
ment by hearing-impaired persons.
The sensitivity analysis showed highly robust out-
comes with respect to the major cost and transition vari-
ables. The variable that most substantially influenced the
base-case estimate was the change in quality of life. The
only other variables that influenced the costs/QALY out-
come were the costs of the hearing aid and the probabil-
ityofbecomingadissatisfiedhearing-aiduser.Inthesen-
sitivity analysis, we assumed that the price of the hearing
aid would not influence the gain in health-related quality
oflife.Inreallife,moreexpensive(eg,digital)hearingaids
mightleadtoalargergaininhealth-relatedqualityoflife.
In future research, the possible extra benefits of more ex-
Table 2. Outcomes Univariate Sensitivity Analysis*
Variables Range of Estimate Range of Costs/QALY, C
First-time hearing-aid applicants
Annual probability to visit GP for hearing-related complaints, %† 2.1/8.2 to 8.6/32.9 15909 to 15720
Diagnostics-and-treatment phase
Annual probability to be referred by GP, % 40 to 70 15691 to 16039
Annual probability to receive prescription for HA, % 62.5 to 87.5 15565 to 16197
Annual probability of negative trial at dispenser, % 3.7 to 11 15652 to 16017
Satisfied and dissatisfied HA users
Annual probability to become dissatisfied, %† 0/0 to 12.2/24.4 11280 to 20283
HA replacement time, y‡ 4.1/7.5 to 12.3/22.5 14402 to 20175
Costs
Proportion binaural fittings, % 10 to 50 14560 to 17948
HA, C 350 to 1000 11209 to 20575
Gain in generic quality-of-life satisfied HA user, 95% CI§ −0.03 to 0.08 −15807 to 5936
Abbreviations: CI, confidence interval; EQ-5D, EuroQol 5 Dimensions; GP, general practitioner; HA, hearing aid; QALY, quality-adjusted life-year.
*Base case, C15807/QALY.
†Based on comparison of patients younger than 60 years vs those 60 years and older.
‡Based on comparison of satisfied-dissatisfied users.
§Reported as the population utility estimate from the EQ-5D.
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tifiedintermsoftheincrementalcost-effectivenessinwell-
defined patient categories. The probability of becoming a
dissatisfied hearing-aid user also influenced the outcome
quite substantially. Therefore, changes in the policy for
fitting hearing aids that would increase the probability of
becoming a dissatisfied hearing-aid user would consider-
ablyincreasetheamountofcosts/QALYforfittingofhear-
ing aids. For instance, screening for hearing impairment
to fit more hearing-impaired persons with hearing aids
could lead to an increase in the probability of becoming a
dissatisfied user when the detected patients are not mo-
tivated to start using hearing aids. Cutting down on the
professional quality and quantity of support for hearing-
aid users might have a similar effect. On the other hand,
extra counseling programs to keep hearing-aid users
motivated are likely to improve the cost-effectiveness of
hearing-aid fitting.
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